| P50 | author | Emily Somers | Q42611546 |
| P2093 | author name string | Wendy Marder | |
| | Évelyne Vinet | |
| P2860 | cites work | Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States | Q24544293 |
| | Clinical practice. Primary ovarian insufficiency | Q24653014 |
| | Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy | Q28139328 |
| | Regulatory roles of sex hormones in cutaneous biology and immunology | Q28241988 |
| | Crossing the Atlantic: the Euro-Lupus Nephritis regimen in North America | Q28645743 |
| | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 |
| | Systemic lupus erythematosus in the elderly: clinical and immunological characteristics | Q33563933 |
| | Effect of menopause on the modified Rodnan skin score in systemic sclerosis | Q33892434 |
| | Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 |
| | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | The epidemiology of autoimmune diseases | Q34212462 |
| | Type I interferons are associated with subclinical markers of cardiovascular disease in a cohort of systemic lupus erythematosus patients | Q34273836 |
| | The epidemiology of rheumatoid arthritis | Q34275961 |
| | Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 |
| | A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness | Q34336337 |
| | Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program | Q34343779 |
| | Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus | Q34426622 |
| | Cardiovascular disease in systemic sclerosis | Q34947193 |
| | Rheumatoid arthritis in women: still associated with an increased mortality. | Q34962868 |
| | Post-menopause is the main risk factor for developing isolated pulmonary hypertension in systemic sclerosis | Q74452900 |
| | Ovarian failure and flares of systemic lupus erythematosus | Q77873043 |
| | Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. SLE Disease Activity Index | Q78248020 |
| | Early menopause and subsequent cardiovascular disease | Q86216307 |
| | Late onset systemic lupus erythematosus in southern Chinese | Q35547972 |
| | Comorbid conditions in patients with rheumatic diseases: an update | Q35652817 |
| | Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis | Q36059617 |
| | Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people, 2007-2009. | Q36198950 |
| | Advances in immunosuppressive drug therapy for use in autoimmune disease and systemic vasculitis | Q36222936 |
| | Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin | Q36274246 |
| | Early menopause and severity of rheumatoid arthritis in women older than 45 years | Q36633422 |
| | Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility | Q37105605 |
| | Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases | Q37438934 |
| | Environmental exposures, epigenetic changes and the risk of lupus | Q37724776 |
| | Menopause in patients with autoimmune diseases | Q37961466 |
| | Low bone density in systemic sclerosis. A systematic review | Q38137769 |
| | Characteristics of patients with late onset systemic lupus erythematosus in Turkey | Q40509836 |
| | Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. | Q40691132 |
| | Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy | Q40748681 |
| | Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus | Q41608189 |
| | A study of the decrease of skin collagen content, skin thickness, and bone mass in the postmenopausal woman | Q41845865 |
| | Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts | Q43096563 |
| | Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study | Q43433825 |
| | Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide | Q43993205 |
| | Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 |
| | Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period | Q44506234 |
| | Effect of age at menopause on disease presentation in early rheumatoid arthritis: results from the Canadian Early Arthritis Cohort | Q44844209 |
| | Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density | Q45013118 |
| | Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. | Q45250470 |
| | Wegener Granulomatosis: An Analysis of 158 Patients | Q45267316 |
| | Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus | Q46687330 |
| | Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women | Q47376722 |
| | Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition | Q49125243 |
| | Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. | Q50701881 |
| | Hormone replacement therapy may prevent the development of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. | Q51763144 |
| | Late onset systemic lupus erythematosus: no substantial differences using different cut-off ages. | Q51772331 |
| | Burden of mortality associated with autoimmune diseases among females in the United Kingdom. | Q51791806 |
| | Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus. | Q51843253 |
| | The effect of menopause on disease activity in systemic lupus erythematosus. | Q53249654 |
| | Scleroderma | Q54165664 |
| | Systemic lupus erythematosus in a multiethnic US cohort: Clinical features, course, and outcome in patients with late-onset disease | Q61811922 |
| | Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program | Q62050411 |
| | Population-based lupus registries: Advancing our epidemiologic understanding | Q62050440 |
| | Clinical features of young women with hypergonadotropic amenorrhea | Q67287005 |
| | Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer | Q67562169 |
| | Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy | Q72849010 |
| | Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 |
| | Do flares of systemic lupus erythematosus decline after menopause? | Q73426082 |
| | The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison | Q73471436 |
| P577 | publication date | 2015-12-02 | |
| P1433 | published in | Women's midlife health | Q27727422 |
| P1476 | title | Rheumatic autoimmune diseases in women and midlife health | |
| P478 | volume | 1 | |